Skip to main content
. 2022 Apr 28;17(5):1033–1047. doi: 10.1016/j.stemcr.2022.03.019

Figure 1.

Figure 1

Workflow of hiPSC-based disease modeling and downstream multi-omics analysis

hiPSC-derived control and disease-specific cell lines are generated either from healthy individuals, patients, or via CRISPR-Cas9 editing. Genomics, transcriptomics, and/or proteomics analyses are performed for each experimental condition. Conditions are cross-compared and interpreted to elucidate disease mechanisms and identify potential therapeutic targets. Created with Biorender.com.